UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 16, 2026
Exercise
Calculated transaction value
$0
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 15, 2026
Public filing date
Sep 16, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$500.35
Sep 15, 2026
Close before public filing
$500.35
Sep 15, 2026
Return since public filing
-1.14%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 9,500 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000142
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$5.88M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 15, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Sep 15, 2026 | $389.82K |
| United Therapeutics Corp UTHR | Sale | Sep 15, 2026 | $1.86M |
| United Therapeutics Corp UTHR | Sale | Sep 15, 2026 | $1.35M |
| United Therapeutics Corp UTHR | Sale | Sep 15, 2026 | $414.62K |
| United Therapeutics Corp UTHR | Sale | Sep 15, 2026 | $425.71K |
| United Therapeutics Corp UTHR | Sale | Sep 15, 2026 | $327.97K |
| United Therapeutics Corp UTHR Current | Exercise | Sep 15, 2026 | $0 |